Surgical and Interventional Approaches in COPD

REFERENCES

1. 1.↵
   1. Miravitlles M,
   2. Worth H,
   3. Soler Cataluña JJ,
   4. Price D,
   5. De Benedetto F,
   6. Roche N,
   7. et al

   . Observational study to characterize 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res 2014;15(1):122.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Mansfield C,
   2. Sutphin J,
   3. Shriner K,
   4. Criner GJ,
   5. Celli BR

   . Patient preferences for endobronchial valve treatment of severe emphysema. Chronic Obstr Pulm Dis 2018;6(1):51-63.

   OpenUrl
3. 3.↵
   1. Marchetti N,
   2. Criner KT,
   3. Keresztury MF,
   4. Furukawa S,
   5. Criner GJ

   . The acute and chronic effects of bullectomy on cardiovascular function at rest and during exercise. J Thorac Cardiovasc Surg 2008;135(1):205-206, 206.e201.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Travaline JM,
   2. Addonizio VP,
   3. Criner GJ

   . Effect of bullectomy on diaphragm strength. Am J Respir Crit Care Med 1995;152(5 Pt 1):1697-1701.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Brantigan OC,
   2. Mueller E,
   3. Kress MB

   . A surgical approach to pulmonary emphysema. Am Rev Respir Dis 1959;80(1, Part 2):194-206.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Cooper JD,
   2. Trulock EP,
   3. Triantafillou AN,
   4. Patterson GA,
   5. Pohl MS,
   6. Deloney PA,
   7. et al

   . Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995;109(1):106-116.discussion 116-109.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Cooper JD,
   2. Patterson GA,
   3. Sundaresan RS,
   4. Trulock EP,
   5. Yusen RD,
   6. Pohl MS,
   7. et al

   . Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996;112(5):1319-1329.discussion 1329-1330.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   The National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. Chest 1999;116(6):1750-1761.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Fishman A,
   2. Martinez F,
   3. Naunheim K,
   4. Piantadosi S,
   5. Wise R,
   6. Ries A,
   7. et al

   . A randomized trial comparing lung-volume reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348(21):2059-2073.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Fishman A,
    2. Fessler H,
    3. Martinez F,
    4. McKenna RJ Jr.,
    5. Naunheim K,
    6. Piantadosi S,
    7. et al

    ; National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume reduction surgery. N Engl J Med 2001;345(15):1075-1083.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Naunheim KS,
    2. Wood DE,
    3. Mohsenifar Z,
    4. Sternberg AL,
    5. Criner GJ,
    6. DeCamp MM,
    7. et al

    ; National Emphysema Treatment Trial Research Group. Long-term follow-up of patients receiving lung volume reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006;82(2):431-443.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Naunheim KS,
    2. Wood DE,
    3. Krasna MJ,
    4. DeCamp MM,
    5. Ginsburg ME,
    6. McKenna RJ,
    7. et al

    ; National Emphysema Treatment Trial Research Group. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006;131(1):43-53.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Greening NJ,
    2. Vaughan P,
    3. Oey I,
    4. Steiner MC,
    5. Morgan MD,
    6. Rathinam S,
    7. et al

    . Individualized risk in patients undergoing lung volume reduction surgery: the Glenfield BFG score. Eur Respir J 2017;49(6):1601766.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Imfeld S,
    2. Bloch KE,
    3. Weder W,
    4. Russi EW

    . The BODE index after lung volume reduction surgery correlates with survival. Chest 2006;129(4):873-878.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. DeCamp MM,
    2. Blackstone EH,
    3. Naunheim KS,
    4. Krasna MJ,
    5. Wood DE,
    6. Meli YM,
    7. et al

    ; NETT Research Group. Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg 2006;82(1):197-206.discussion 206-197.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Chandra D,
    2. Lipson DA,
    3. Hoffman EA,
    4. Hansen-Flaschen J,
    5. Sciurba FC,
    6. Decamp MM,
    7. et al

    ; National Emphysema Treatment Trial Research Group. Perfusion scintigraphy and patient selection for lung volume reduction surgery. Am J Respir Crit Care Med 2010;182(7):937-946.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Caviezel C,
    2. Schaffter N,
    3. Schneiter D,
    4. Franzen D,
    5. Inci I,
    6. Opitz I,
    7. et al

    . Outcome after lung volume reduction surgery in patients with severely impaired diffusion capacity. Ann Thorac Surg 2018;105(2):379-385.

    OpenUrlCrossRef
18. 18.↵
    1. Caviezel C,
    2. Froehlich T,
    3. Schneiter D,
    4. Muehlematter U,
    5. Frauenfelder T,
    6. Guglielmetti LC,
    7. et al

    . Identification of target zones for lung volume reduction surgery using three-dimensional computed tomography rendering. ERJ Open Res 2020;6(3):00305-2020.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Washko GR,
    2. Fan VS,
    3. Ramsey SD,
    4. Mohsenifar Z,
    5. Martinez F,
    6. Make BJ,
    7. et al

    ; National Emphysema Treatment Trial Research Group. The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008;177(2):164-169.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Kim V,
    2. Kretschman DM,
    3. Sternberg AL,
    4. DeCamp MM,
    5. Criner GJ

    ; Group NETTR. Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency. Am J Respir Crit Care Med 2012;186(11):1109-1116.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Criner GJ,
    2. Belt P,
    3. Sternberg AL,
    4. Mosenifar Z,
    5. Make BJ,
    6. Utz JP,
    7. et al

    ; National Emphysema Treatment Trial Research Group. Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise. Chest 2009;135(5):1268-1279.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Come CE,
    2. Divo MJ,
    3. San José Estépar R,
    4. Sciurba FC,
    5. Criner GJ,
    6. Marchetti N,
    7. et al

    ; NETT Research Group. Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respir Med 2012;106(1):109-119.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Jörgensen K,
    2. Houltz E,
    3. Westfelt U,
    4. Ricksten SE

    . Left ventricular performance and dimensions in patients with severe emphysema. Anesth Analg 2007;104(4):887-892.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Clarenbach CF,
    2. Sievi NA,
    3. Brock M,
    4. Schneiter D,
    5. Weder W,
    6. Kohler M

    . Lung volume reduction surgery and improvement of endothelial function and blood pressure in patients with chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med 2015;192(3):307-314.

    OpenUrlPubMed
25. 25.↵
    1. Ginsburg ME,
    2. Thomashow BM,
    3. Bulman WA,
    4. Jellen PA,
    5. Whippo BA,
    6. Chiuzan C,
    7. et al

    . The safety, efficacy, and durability of lung volume reduction surgery: a 10-year experience. J Thorac Cardiovasc Surg 2016;151(3):717-724.e711.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Stanifer BP,
    2. Ginsburg ME

    . Lung volume reduction surgery in the post-National Emphysema Treatment Trial era. J Thorac Dis 2018;10(Suppl 23):S2744-S2747.

    OpenUrl
27. 27.↵
    1. Abdelsattar ZM,
    2. Allen M,
    3. Blackmon S,
    4. Cassivi S,
    5. Mandrekar J,
    6. Nichols F,
    7. et al

    . Contemporary practice patterns of lung volume reduction surgery in the United States. Ann Thorac Surg 2021;112(3):952-960.

    OpenUrl
28. 28.↵
    1. Buttery S,
    2. Lewis A,
    3. Oey I,
    4. Hargrave J,
    5. Waller D,
    6. Steiner M,
    7. et al

    . Patient experience of lung volume reduction procedures for emphysema: a qualitative service improvement project. ERJ Open Res 2017;3(3):00031-2017.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. McNulty W,
    2. Jordan S,
    3. Hopkinson NS

    . Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society. BMJ Open Respir Res 2014;1(1):e000023.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Rathinam S,
    2. Oey I,
    3. Steiner M,
    4. Spyt T,
    5. Morgan MD,
    6. Waller DA

    . The role of the emphysema multidisciplinary team in a successful lung volume reduction surgery program. Eur J Cardiothorac Surg 2014;46(6):1021-1026.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Ramsey SD,
    2. Berry K,
    3. Etzioni R,
    4. Kaplan RM,
    5. Sullivan SD,
    6. Wood DE,
    7. et al

    . Cost effectiveness of lung volume reduction surgery for patients with severe emphysema. N Engl J Med 2003;348(21):2092-2102.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.↵
    1. Sciurba FC,
    2. Ernst A,
    3. Herth FJ,
    4. Strange C,
    5. Criner GJ,
    6. Marquette CH,
    7. et al

    ; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010;363(13):1233-1244.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.↵
    1. Klooster K,
    2. ten Hacken NH,
    3. Hartman JE,
    4. Kerstjens HA,
    5. van Rikxoort EM,
    6. Slebos DJ

    . Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 2015;373(24):2325-2335.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Kemp SV,
    2. Slebos DJ,
    3. Kirk A,
    4. Kornaszewska M,
    5. Carron K,
    6. Ek L,
    7. et al

    ; TRANSFORM Study Team. A multi-center randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med 2017;196(12):1535-1543.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Criner GJ,
    2. Sue R,
    3. Wright S,
    4. Dransfield M,
    5. Rivas-Perez H,
    6. Wiese T,
    7. et al

    ; LIBERATE Study Group. A multi-center randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med 2018;198(9):1151-1164.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Li S,
    2. Wang G,
    3. Wang C,
    4. Gao X,
    5. Jin F,
    6. Yang H,
    7. et al

    . The REACH trial: a randomized controlled trial assessing the safety and effectiveness of the spiration valve system in the treatment of severe emphysema. Respiration 2019;97(5):416-427.

    OpenUrlCrossRef
37. 37.↵
    1. Criner GJ,
    2. Delage A,
    3. Voelker K,
    4. Hogarth DK,
    5. Majid A,
    6. Zgoda M,
    7. et al

    . Improving lung function in severe heterogenous emphysema with the spiration valve system (EMPROVE): a multi-center, open-label, randomized controlled trial. Am J Respir Crit Care Med 2019;200(11):1354-1362.

    OpenUrl
38. 38.↵
    1. Patel M,
    2. Chowdhury J,
    3. Zhao H,
    4. Lu X,
    5. Roth S,
    6. Giovacchini CX,
    7. et al

    . Meta-analysis and systematic review of bronchoscopic lung volume reduction through endobronchial valves in severe emphysema. J Bronchology Interv Pulmonol 2022;29(3):224-237.

    OpenUrl
39. 39.↵
    1. Valipour A,
    2. Slebos DJ,
    3. Herth F,
    4. Darwiche K,
    5. Wagner M,
    6. Ficker JH,
    7. et al

    ; IMPACT Study Team. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study. Am J Respir Crit Care Med 2016;194(9):1073-1082.

    OpenUrlCrossRef
40. 40.↵
    1. Eberhardt R,
    2. Slebos DJ,
    3. Herth FJF,
    4. Darwiche K,
    5. Wagner M,
    6. Ficker JH,
    7. et al

    ; IMPACT Study Team. Endobronchial valve (Zephyr) treatment in homogeneous emphysema: one-year results from the IMPACT randomized clinical trial. Respiration 2021;100(12):1174-1185.

    OpenUrl
41. 41.↵
    1. Fiorelli A,
    2. D’Andrilli A,
    3. Bezzi M,
    4. Ibrahim M,
    5. Anile M,
    6. Diso D,
    7. et al

    . Complications related to endoscopic lung volume reduction for emphysema with endobronchial valves: results of a multi-center study. J Thorac Dis 2018;10(Suppl 27):S3315-S3325.

    OpenUrl
42. 42.↵
    1. Roodenburg SA,
    2. Klooster K,
    3. Hartman JE,
    4. Koster TD,
    5. van Dijk M,
    6. Slebos DJ

    . Revision bronchoscopy after endobronchial valve treatment for emphysema: indications, findings, and outcomes. Int J Chron Obstruct Pulmon Dis 2021;16:1127-1136.

    OpenUrl
43. 43.↵
    1. Ing A,
    2. Sullivan C,
    3. Hersch N,
    4. Saghaie T,
    5. Williamson J

    . Reversal of collateral ventilation using endobronchial polymer sealant in a patient with emphysema undergoing endoscopic lung volume reduction (ELVR) with valves: a case report and proof of concept. J Bronchology Interv Pulmonol 2020;27(1):e14-e16.

    OpenUrl
44. 44.↵
    1. Sciurba FC,
    2. Criner GJ,
    3. Strange C,
    4. Shah PL,
    5. Michaud G,
    6. Connolly TA,
    7. et al

    ; RENEW Study Research Group. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA 2016;315(20):2178-2189.

    OpenUrlCrossRef
45. 45.↵
    1. Criner GJ,
    2. Pinto-Plata V,
    3. Strange C,
    4. Dransfield M,
    5. Gotfried M,
    6. Leeds W,
    7. et al

    . Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results. Am J Respir Crit Care Med 2009;179(9):791-798.

    OpenUrlCrossRefPubMedWeb of Science
46. 46.↵
    1. Refaely Y,
    2. Dransfield M,
    3. Kramer MR,
    4. Gotfried M,
    5. Leeds W,
    6. McLennan G,
    7. et al

    . Biologic lung volume reduction therapy for advanced homogeneous emphysema. Eur Respir J 2010;36(1):20-27.

    OpenUrlAbstract/FREE Full Text
47. 47.↵
    1. Herth FJ,
    2. Gompelmann D,
    3. Stanzel F,
    4. Bonnet R,
    5. Behr J,
    6. Schmidt B,
    7. et al

    . Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal). Respiration 2011;82(1):36-45.

    OpenUrlCrossRefPubMedWeb of Science
48. 48.↵
    1. Kramer MR,
    2. Refaely Y,
    3. Maimon N,
    4. Rosengarten D,
    5. Fruchter O

    . Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest 2012;142(5):1111-1117.

    OpenUrlCrossRefPubMedWeb of Science
49. 49.↵
    1. Ing AJ,
    2. Jayapadman A,
    3. Kim WV,
    4. Ly C,
    5. Ho-Shon K,
    6. Lilburn P,
    7. et al

    . Reversal of collateral ventilation using endoscopic polymer foam in COPD patients undergoing endoscopic lung volume reduction with endobronchial valves: a controlled parallel group trial. Respirology 2022;27(12):1064-1072.

    OpenUrl
50. 50.↵
    1. Shah PL,
    2. Slebos DJ,
    3. Cardoso PF,
    4. Cetti E,
    5. Voelker K,
    6. Levine B,
    7. et al

    ; EASE trial study group. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomized, sham-controlled, multi-center trial. Lancet 2011;378(9795):997-1005.

    OpenUrlCrossRefPubMedWeb of Science
51. 51.↵
    1. Snell G,
    2. Herth FJ,
    3. Hopkins P,
    4. Baker KM,
    5. Witt C,
    6. Gotfried MH,
    7. et al

    . Bronchoscopic thermal vapor ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012;39(6):1326-1333.

    OpenUrlAbstract/FREE Full Text
52. 52.↵
    1. Herth FJ,
    2. Valipour A,
    3. Shah PL,
    4. Eberhardt R,
    5. Grah C,
    6. Egan J,
    7. et al

    . Segmental volume reduction using thermal vapor ablation in patients with severe emphysema: 6-month results of the multi-center, parallel-group, open-label, randomized controlled STEP-UP trial. Lancet Respir Med 2016;4(3):185-193.

    OpenUrl
53. 53.↵
    1. Shah PL,
    2. Gompelmann D,
    3. Valipour A,
    4. McNulty WH,
    5. Eberhardt R,
    6. Grah C,
    7. et al

    . Thermal vapor ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results. Lancet Respir Med 2016;4(9):e44-e45.

    OpenUrl
54. 54.↵
    1. Slebos DJ,
    2. Breen D,
    3. Coad J,
    4. Klooster K,
    5. Hartman J,
    6. Browning R,
    7. et al

    . Safety and histological effect of liquid nitrogen–metered spray cryotherapy in the lung. Am J Respir Crit Care Med 2017;196(10):1351-1352.

    OpenUrl
55. 55.↵
    1. Garner JL,
    2. Shaipanich T,
    3. Hartman JE,
    4. Orton CM,
    5. Caneja C,
    6. Klooster K,
    7. et al

    . A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD. Eur Respir J 2020;56(6):2000556.

    OpenUrlAbstract/FREE Full Text
56. 56.↵
    Clinicaltrials.gov. RejuvenAir System Trial for COPD With Chronic Bronchitis (SPRAY-CB). Available at: https://clinicaltrials.gov/ct2/show/NCT03893370?term=spray+cb&cond=Chronic+Bronchitis&draw=2.
57. 57.↵
    1. Valipour A,
    2. Fernandez-Bussy S,
    3. Ing AJ,
    4. Steinfort DP,
    5. Snell GI,
    6. Williamson JP,
    7. et al

    . Bronchial rheoplasty for treatment of chronic bronchitis. Twelve-month results from a multi-center clinical trial. Am J Respir Crit Care Med 2020;202(5):681-689.

    OpenUrlPubMed
58. 58.↵
    Clinicaltrials.gov. Clinical study of the RheOx bronchial rheoplasty system in treating the symptoms of chronic bronchitis. Available at: https://clinicaltrials.gov/ct2/show/NCT04677465?term=chronic+bronchitis&cond=rheoplasty&draw=2&rank=1.
59. 59.↵
    Clinicaltrials.gov. Evaluation of the Safety and Efficacy of TLD in Patients With COPD (AIRFLOW-3). Available at: https://clinicaltrials.gov/ct2/show/NCT03639051?term=AIRFLOW&cond=COPD&draw=2&rank=9.
60. 60.↵
    1. Chambers DC,
    2. Cherikh WS,
    3. Goldfarb SB,
    4. Hayes D,
    5. Kucheryavaya AY,
    6. Toll AE,
    7. et al

    ; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation. J Heart Lung Transplant 2018;37(10):1169-1183.

    OpenUrlCrossRefPubMed
61. 61.↵
    1. Weill D,
    2. Benden C,
    3. Corris PA,
    4. Dark JH,
    5. Davis RD,
    6. Keshavjee S,
    7. et al

    . A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015;34(1):1-15.

    OpenUrlCrossRefPubMed
62. 62.↵
    1. Arjuna A,
    2. Olson MT,
    3. Walia R

    . Current trends in candidate selection, contraindications, and indications for lung transplantation. J Thorac Dis 2021;13(11):6514-6527.

    OpenUrl
63. 63.↵
    1. Christie JD,
    2. Edwards LB,
    3. Kucheryavaya AY,
    4. Benden C,
    5. Dipchand AI,
    6. Dobbels F,
    7. et al

    ; International Society of Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012;31(10):1073-1086.

    OpenUrlCrossRefPubMedWeb of Science
64. 64.↵
    1. Marchetti N,
    2. Criner GJ

    . Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation. Semin Respir Crit Care Med 2015;36(4):592-608.

    OpenUrl
65. 65.↵
    1. Stavem K,
    2. Bjørtuft Ø,
    3. Borgan Ø,
    4. Geiran O,
    5. Boe J

    . Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit. J Heart Lung Transplant 2006;25(1):75-84.

    OpenUrlCrossRefPubMedWeb of Science
66. 66.↵
    1. Tanash HA,
    2. Riise GC,
    3. Hansson L,
    4. Nilsson PM,
    5. Piitulainen E

    . Survival benefit of lung transplantation in individuals with severe α1-anti-trypsin deficiency (PiZZ) and emphysema. J Heart Lung Transplant 2011;30(12):1342-1347.

    OpenUrlCrossRefPubMed
67. 67.↵
    1. Tanash HA,
    2. Riise GC,
    3. Ekström MP,
    4. Hansson L,
    5. Piitulainen E

    . Survival benefit of lung transplantation for chronic obstructive pulmonary disease in Sweden. Ann Thorac Surg 2014;98(6):1930-1935.

    OpenUrl
68. 68.↵
    1. Eskander A,
    2. Waddell TK,
    3. Faughnan ME,
    4. Chowdhury N,
    5. Singer LG

    . BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation. J Heart Lung Transplant 2011;30(12):1334-1341.

    OpenUrlCrossRefPubMedWeb of Science
69. 69.↵
    1. Lahzami S,
    2. Bridevaux PO,
    3. Soccal PM,
    4. Wellinger J,
    5. Robert JH,
    6. Ris HB,
    7. et al

    . Survival impact of lung transplantation for COPD. Eur Respir J 2010;36(1):74-80.

    OpenUrlAbstract/FREE Full Text
70. 70.↵
    1. Thabut G,
    2. Ravaud P,
    3. Christie JD,
    4. Castier Y,
    5. Fournier M,
    6. Mal H,
    7. et al

    . Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177(10):1156-1163.

    OpenUrlCrossRefPubMedWeb of Science
71. 71.↵
    ISHLT: The International Society for Heart and Lung Transplantation. Slide Sets - Overall Lung Transplantation Statistics. Available at: https://ishltregistries.org/registries/slides.asp. Accessed May 25, 2023.
72. 72.↵
    1. Thabut G,
    2. Christie JD,
    3. Ravaud P,
    4. Castier Y,
    5. Brugière O,
    6. Fournier M,
    7. et al

    . Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008;371(9614):744-751.

    OpenUrlCrossRefPubMedWeb of Science
73. 73.↵
    1. Pochettino A,
    2. Kotloff RM,
    3. Rosengard BR,
    4. Arcasoy SM,
    5. Blumenthal NP,
    6. Kaiser LR,
    7. et al

    . Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg 2000;70(6):1813-1818.discussion 1818-1819.

    OpenUrlCrossRefPubMedWeb of Science
74. 74.↵
    1. Dickson RP,
    2. Davis RD,
    3. Rea JB,
    4. Palmer SM

    . High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006;25(11):1297-1301.

    OpenUrlCrossRefPubMedWeb of Science
75. 75.↵
    1. Gonzalez FJ,
    2. Alvarez E,
    3. Moreno P,
    4. Poveda D,
    5. Ruiz E,
    6. Fernandez AM,
    7. et al

    . The influence of the native lung on early outcomes and survival after single lung transplantation. PLoS One 2021;16(4):e0249758.

    OpenUrlPubMed
76. 76.↵
    1. Minai OA,
    2. Shah S,
    3. Mazzone P,
    4. Budev MM,
    5. Sahoo D,
    6. Murthy S,
    7. et al

    . Bronchogenic carcinoma after lung transplantation: characteristics and outcomes. J Thorac Oncol 2008;3(12):1404-1409.

    OpenUrlCrossRefPubMed
77. 77.↵
    1. Weill D,
    2. Torres F,
    3. Hodges TN,
    4. Olmos JJ,
    5. Zamora MR

    . Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant 1999;18(11):1080-1087.

    OpenUrlCrossRefPubMedWeb of Science
78. 78.↵
    1. Yonan NA,
    2. el-Gamel A,
    3. Egan J,
    4. Kakadellis J,
    5. Rahman A,
    6. Deiraniya AK

    . Single lung transplantation for emphysema: predictors for native lung hyperinflation. J Heart Lung Transplant 1998;17(2):192-201.

    OpenUrlPubMedWeb of Science
79. 79.↵
    1. Benvenuto LJ,
    2. Costa J,
    3. Piloni D,
    4. Aversa M,
    5. Anderson MR,
    6. Shah L,
    7. et al

    . Right single lung transplantation or double lung transplantation compared with left single lung transplantation in chronic obstructive pulmonary disease. J Heart Lung Transplant 2020;39(9):870-877.

    OpenUrl
80. 80.↵
    1. Mal H,
    2. Brugière O,
    3. Sleiman C,
    4. Rullon I,
    5. Jebrak G,
    6. Groussard O,
    7. et al

    . Morbidity and mortality related to the native lung in single lung transplantation for emphysema. J Heart Lung Transplant 2000;19(2):220-223.

    OpenUrlCrossRefPubMedWeb of Science
81. 81.↵
    1. Ramos KJ,
    2. Harhay MO,
    3. Mulligan MS

    . Which shall I choose? Lung transplantation listing preference for individuals with interstitial lung disease and chronic obstructive pulmonary disease. Ann Am Thorac Soc 2019;16(2):193-195.

    OpenUrl
82. 82.↵
    1. Bavaria JE,
    2. Pochettino A,
    3. Kotloff RM,
    4. Rosengard BR,
    5. Wahl PM,
    6. Roberts JR,
    7. et al

    . Effect of volume reduction on lung transplant timing and selection for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1998;115(1):9-17.discussion 17-18.

    OpenUrlCrossRefPubMedWeb of Science
83. 83.
    1. Senbaklavaci O,
    2. Wisser W,
    3. Ozpeker C,
    4. Marta G,
    5. Jaksch P,
    6. Wolner E,
    7. et al

    . Successful lung volume reduction surgery brings patients into better condition for later lung transplantation. Eur J Cardiothorac Surg 2002;22(3):363-367.

    OpenUrlCrossRefPubMed
84. 84.↵
    1. Slama A,
    2. Taube C,
    3. Kamler M,
    4. Aigner C

    . Lung volume reduction followed by lung transplantation-considerations on selection criteria and outcome. J Thorac Dis 2018;10(Suppl 27):S3366-S3375.

    OpenUrl
85. 85.↵
    1. Reece TB,
    2. Mitchell JD,
    3. Zamora MR,
    4. Fullerton DA,
    5. Cleveland JC,
    6. Pomerantz M,
    7. et al

    . Native lung volume reduction surgery relieves functional graft compression after single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 2008;135(4):931-937.

    OpenUrlCrossRefPubMedWeb of Science
86. 86.
    1. Anderson MB,
    2. Kriett JM,
    3. Kapelanski DP,
    4. Perricone A,
    5. Smith CM,
    6. Jamieson SW

    . Volume reduction surgery in the native lung after single lung transplantation for emphysema. J Heart Lung Transplant 1997;16(7):752-757.

    OpenUrlPubMed
87. 87.
    1. Crespo MM,
    2. Johnson BA,
    3. McCurry KR,
    4. Landreneau RJ,
    5. Sciurba FC

    . Use of endobronchial valves for native lung hyperinflation associated with respiratory failure in a single lung transplant recipient for emphysema. Chest 2007;131(1):214-216.

    OpenUrlCrossRefPubMed
88. 88.
    1. Venuta F,
    2. De Giacomo T,
    3. Rendina EA,
    4. Della Rocca G,
    5. Flaishman I,
    6. Guarino E,
    7. et al

    . Thoracoscopic volume reduction of the native lung after single lung transplantation for emphysema. Am J Respir Crit Care Med 1998;157(1):292-293.

    OpenUrlPubMed
89. 89.
    1. Kemp SV,
    2. Carby M,
    3. Cetti EJ,
    4. Herth FJ,
    5. Shah PL

    . A potential role for endobronchial valves in patients with lung transplant. J Heart Lung Transplant 2010;29(11):1310-1312.

    OpenUrlCrossRefPubMed
90. 90.↵
    1. Perch M,
    2. Riise GC,
    3. Hogarth K,
    4. Musani AI,
    5. Springmeyer SC,
    6. Gonzalez X,
    7. et al

    . Endoscopic treatment of native lung hyperinflation using endobronchial valves in single lung transplant patients: a multinational experience. Clin Respir J 2015;9(1):104-110.

    OpenUrl
91. 91.↵
    1. Shigemura N,
    2. Gilbert S,
    3. Bhama JK,
    4. Crespo MM,
    5. Zaldonis D,
    6. Pilewski JM,
    7. et al

    . Lung transplantation after lung volume reduction surgery. Transplantation 2013;96(4):421-425.

    OpenUrlCrossRefPubMedWeb of Science
92. 92.↵
    1. Slama A,
    2. Ceulemans L,
    3. Hedderich C,
    4. Boehm P,
    5. Van Slambrouck J,
    6. Schwarz S,
    7. et al

    . Lung volume reduction followed by lung transplantation in emphysema-a multi-center matched analysis. Transpl Int 2022;35:1-9.

    OpenUrl
93. 93.↵
    1. Fuehner T,
    2. Clajus C,
    3. Fuge J,
    4. Jonigk D,
    5. Welte T,
    6. Haverich A,
    7. et al

    . Lung transplantation after endoscopic lung volume reduction. Respiration 2015;90(3):243-250.

    OpenUrl